Royce & Associates LP GENMARK DIAGNOSTICS INC Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
N/A
-12,000 Closed
0 $0
Q2 2020

Aug 07, 2020
SELL
N/A
-19,100 Reduced 61.41%
12,000 $177,000
Q3 2019

Nov 13, 2019
SELL
N/A
-45,000 Reduced 59.13%
31,100 $188,000
Q4 2018

Feb 11, 2019
SELL
N/A
-12,600 Reduced 14.21%
76,100 $370,000
Q2 2018

Aug 09, 2018
SELL
N/A
-14,700 Reduced 14.22%
88,700 $566,000
Q1 2018

May 14, 2018
BUY
N/A
37,500 Added 56.9%
103,400 $562,000
Q4 2017

Feb 09, 2018
BUY
N/A
65,900
65,900 $275,000
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email